367 results on '"del Papa, Nicoletta"'
Search Results
2. Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee
3. Does the Impact of COVID‐19 on Patients With Systemic Sclerosis Change Over Time?
4. Rituximab retention rate in systemic sclerosis: a long term real-life multicenter study
5. Dysregulation of circulating collagen turnover markers in very early systemic sclerosis
6. Response to antifibrotic therapy and decrease of circulating BAG3 protein levels in systemic sclerosis patients with reduced forced vital capacity
7. Surgical treatment of recalcitrant gastroesophageal reflux disease in patients with systemic sclerosis: a systematic review
8. Autologous stem cell transplantation in scleroderma
9. Does the impact of COVID-19 on patients with systemic sclerosis change over time?
10. Adipose-Derived Stem Cells to Facilitate Ulcer Healing: Future Strategies
11. Overexpression of BAG3 (Bcl2-Associated Athanogene 3) in Serum and Skin of Patients with Systemic Sclerosis
12. Herpes zoster in lupus nephritis: experience on 292 patients followed up for 15 years
13. Belimumab may decrease flare rate and allow glucocorticoid withdrawal in lupus nephritis (including dialysis and transplanted patient)
14. Clinical, serological and radiological features of a prospective cohort of Interstitial Pneumonia with Autoimmune Features (IPAF) patients
15. Does the impact of COVID‐19 on patients with systemic sclerosis change over time?
16. Taking care of systemic sclerosis patients during COVID-19 pandemic: rethink the clinical activity
17. High NEMO score values in nailfold videocapillaroscopy are associated with the subsequent development of ischaemic digital ulcers in patients with systemic sclerosis
18. Regional grafting of autologous adipose tissue is effective in inducing prompt healing of indolent digital ulcers in patients with systemic sclerosis: results of a monocentric randomized controlled study
19. NEMO score in nailfold videocapillaroscopy is a good tool to assess both steady state levels and overtime changes of disease activity in patients with systemic sclerosis: a comparison with the proposed composite indices for this disease status entity
20. Adipose-Derived Stem Cells to Facilitate Ulcer Healing: Future Strategies
21. Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study
22. Belimumab may decrease flare rate and allow glucocorticoid withdrawal in lupus nephritis (including dialysis and transplanted patient)
23. New insights in systemic lupus erythematosus: From regulatory T cells to CAR-T-cell strategies
24. Profibrotic Effects of Endothelin-1 on Fibroblasts Are Mediated by Aldosterone In Vitro: Relevance to the Pathogenesis and Therapy of Systemic Sclerosis and Pulmonary Arterial Hypertension
25. Cellular-Based Therapies in Systemic Sclerosis: From Hematopoietic Stem Cell Transplant to Innovative Approaches
26. Classification and diagnostic criteria in Sjögren’s syndrome: a long-standing and still open controversy
27. Peripheral Microangiopathy Changes in Pulmonary Arterial Hypertension Related to Systemic Sclerosis: Data From a Multicenter Observational Study
28. Long-term kidney outcome of patients with rheumatological diseases and antineutrophil cytoplasmic antibody-glomerulonephritis: comparison with a primitive ANCA-glomerulonephritis cohort
29. A New Method for the Assessment of Myalgia in Interstitial Lung Disease: Association with Positivity for Myositis-Specific and Myositis-Associated Antibodies
30. Adipose-derived cell transplantation in systemic sclerosis: state of the art and future perspectives
31. Breakthrough Infections in COVID-19 Vaccinated Patients with Systemic Sclerosis: A Survival Analysis from a Multicenter International Patient-Reported Survey
32. BAG3 induces α‐SMA expression in human fibroblasts and its over‐expression correlates with poorer survival in fibrotic cancer patients
33. A Die-Hard Giant Capillary
34. Intestinal Microbiome in Hematopoietic Stem Cell Transplantation For Autoimmune Diseases: Considerations and Perspectives on Behalf of Autoimmune Diseases Working Party (ADWP) of the EBMT
35. Interstitial Lung Disease Associated With Autoimmune Rheumatic Diseases: Checklists for Clinical Practice
36. Is adipose-tissue (or its fraction) grafting really effective in the treatment of scleroderma hand?
37. Impact and outcome of COVID-19 on SSc-ILD
38. Instruments for Outcome Evaluation of Specific Domains in Primary Sjögren’s Syndrome
39. Management of Sjögren's Syndrome: Present Issues and Future Perspectives
40. "Usual" interstitial pneumonia with autoimmune features: a prospective study on a cohort of idiopathic pulmonary fibrosis patients
41. Intestinal Microbiome in Hematopoietic Stem Cell Transplantation For Autoimmune Diseases : Considerations and Perspectives on Behalf of Autoimmune Diseases Working Party (ADWP) of the EBMT
42. Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19 : EBMT guidelines and recommendations
43. Interstitial Lung Disease Associated With Autoimmune Rheumatic Diseases: Checklists for Clinical Practice
44. A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: The UPSIDE study protocol
45. Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: a clinical observational study
46. Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis: A Randomized Clinical Trial
47. The Morphological Domain Does Not Affect the Rate of Progression to Defined Autoimmune Diseases in Patients With Interstitial Pneumonia With Autoimmune Features
48. Haematopoietic stem cell transplantation for severe autoimmune diseases in children: A review of current literature, registry activity and future directions on behalf of the autoimmune diseases and paediatric diseases working parties of the European Society for Blood and Marrow Transplantation
49. Undifferentiated connective tissue disease at risk for systemic sclerosis: Development of a short-term predictive score and a risk stratification tool
50. A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: the UPSIDE study protocol
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.